| | | |   | | | | By Rachel Cohrs and Ed Silverman Sergio Flores/Getty Images The Biden administration wants to rein in pharmacy fees charged by controversial drug middlemen in Medicare. Read More | | By Ed Silverman Adobe A new analysis finds there is transparency is lacking around pharma donations to patient advocacy groups in Canada. Read More | | By Andrew Joseph Pfizer Doctors have an arsenal of different Covid-19 treatments, but setbacks and shortages are undercutting the options. Read More | | Sponsor content by Amgen How does a molecule go from discovery to development? Getting a medicine from the lab into the hands of patients doesn't come easily, as David Reese, Executive Vice President, Research and Development at Amgen, will tell you. "It takes more than a village — it takes an army that has worked for many years. That's why we're here, it's why I come to work every day." Hear from David, scientists, and researchers about what it takes to bring a molecule from discovery to development. | | By Ed Silverman Alex Hogan/STAT From new hires to departures, promotions, and transfers, here are the latest comings and goings in the pharmaceutical industry. Read More | | By Reshma Ramachandran and Tianna Zhou and Joseph S. Ross Adobe For Medicare-covered seniors with chronic conditions, out-of-pocket costs for medications increased by more than 40% between 2009 and 2019. Read More | |
No comments